DCM
CGON icon

Driehaus Capital Management’s CG Oncology CGON Stock Holding History

Driehaus Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.7M Buy
+999,623
New +$56.6M 0.5% 57
2025
Q1 		– Sell
-197,937
Closed -$5.68M – 413
2024
Q4 		$5.68M Sell
197,937
-2,046
-1% -$70K 0.05% 287
2024
Q3 		$7.55M Buy
199,983
+93,032
+87% +$3.26M 0.06% 251
2024
Q2 		$3.38M Sell
106,951
-1,006
-0.9% -$34.9K 0.03% 273
2024
Q1 		$4.74M Buy
+107,957
New +$4.41M 0.05% 282

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Driehaus Capital Management's CGON Position: Q1 2026 in Review

Driehaus Capital Management opened a new position in CG Oncology (CGON) in Q1 2026: 999,623 shares worth $67.7M. The stake represents 0.5% of the portfolio and ranks #57 among its holdings. This is a return to the name: Driehaus Capital Management previously reported a position in CGON as recently as Q4 2024.

Driehaus Capital Management first reported a position in CGON in Q1 2024 and has held it in 5 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Driehaus Capital Management held 999,623 shares of CG Oncology worth $67.7M as of Q1 2026.
  • CG Oncology was a new Driehaus Capital Management position in Q1 2026.
  • CG Oncology made up 0.5% of Driehaus Capital Management's portfolio in Q1 2026, its #57 holding.
  • Driehaus Capital Management first reported a position in CG Oncology in Q1 2024 and has held it in 5 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.